Suzhou Ribo Life Science Co（06938.HK）价格

Suzhou Ribo Life Science Co Ltd is a CN-based company operating in industry. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2026-01-09. Suzhou Ribo Life Science Co Ltd is a China-based company primarily engaged in the oligonucleotide research and development, with a focus on small interfering ribonucleic acid (siRNA) therapeutics. The firm is engaged in the oligonucleotide drug innovation focused on cardiovascular, metabolic, renal and liver diseases, as well as other therapeutic areas. The Company’s drug pipelines include RBD4059, RBD5044, RBD7022, RBD7007, RBD2080, RBD1119, RBD1016 and others. The firm mainly conducts its business in the domestic market.